TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

Why Is Medtronic Stock Trading Higher After Analyst Upgrade

Benzinga Logo Benzinga By Vandana Singh
Why Is Medtronic Stock Trading Higher After Analyst Upgrade

William Blair upgraded Medtronic (MDT) from Market Perform to Outperform, citing new product launches and ramping growth drivers including the Hugo surgical system, Symplicity Spyral RDN system, and Pulsed Field Ablation platform. The analyst noted the stock trades at a favorable valuation of ~16x 2026 EPS with potential for low-double-digit equity returns including dividend yield. Medtronic shares rose 2.91% following the upgrade.

Insights
LLY   neutral

Mentioned briefly as part of national efforts to improve medication affordability, with no specific actions detailed


MDT   positive

Upgraded from Market Perform to Outperform by William Blair based on multiple growth catalysts including new product launches (Hugo system, Symplicity Spyral RDN, PFA platform), favorable valuation at 16x 2026 EPS, potential for high-single-digit EPS growth and low-double-digit equity returns, plus improved visibility from CMS reimbursement decisions. Stock price increased 2.91% on the upgrade.